IMPLAVAX Trademark

Trademark Overview


On Tuesday, March 20, 2018, a trademark application was filed for IMPLAVAX with the United States Patent and Trademark Office. The USPTO has given the IMPLAVAX trademark a serial number of 79233134. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, October 10, 2025. This trademark is owned by Enesi Pharma Limited. The IMPLAVAX trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical and veterinary preparations and substances for the treatment of and protection against infectious and autoimmune diseases; pharmaceutical and veterinary preparations and substances for the treatment of or protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substances against infectious and autoimmune diseases; vaccines, prophylactic vaccines, therapeutic vaccines; contraceptive preparations and substances

Surgical, medical, dental and veterinary apparatus and instruments, namely, drug delivery systems for delivery of drugs and vaccines; needle-free drug delivery systems sold empty; actuator devices, namely, medical solid dose injectors sold empty for injecting pharmaceutical and veterinary preparations into the skin; drug cassettes in the nature of drug and vaccine delivery systems sold empty; medical needle-free injection systems, needle-free injectors, namely, injection devices for administering drugs and vaccines sold empty; drug delivery injection devices for administering drugs and vaccines, namely, medical injectors, needle-free injectors and structural parts therefor sold empty; actuator devices for use in drug delivery devices, namely, handheld spring-powered devices in the nature of needle-free injection systems for injecting pharmaceutical and veterinary preparations into the skin sold empty; drug cassettes for use in drug delivery devices in the nature of drug and vaccine del...
implavax

General Information


Serial Number79233134
Word MarkIMPLAVAX
Filing DateTuesday, March 20, 2018
Status709 - CANCELLED - SECTION 71
Status DateFriday, October 10, 2025
Registration Number5706102
Registration DateTuesday, March 26, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2019

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations and substances for the treatment of and protection against infectious and autoimmune diseases; pharmaceutical and veterinary preparations and substances for the treatment of or protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substances against infectious and autoimmune diseases; vaccines, prophylactic vaccines, therapeutic vaccines; contraceptive preparations and substances
Amendment to a Registration/Renewal CertificateIssue New Certificate to: "Enesi Pharma Limited (Great Britian Limited UK Company), 120 A&B Olympic Avenue, Milton Park, Abingdon, Oxfordshire OX144SA"
Goods and ServicesSurgical, medical, dental and veterinary apparatus and instruments, namely, drug delivery systems for delivery of drugs and vaccines; needle-free drug delivery systems sold empty; actuator devices, namely, medical solid dose injectors sold empty for injecting pharmaceutical and veterinary preparations into the skin; drug cassettes in the nature of drug and vaccine delivery systems sold empty; medical needle-free injection systems, needle-free injectors, namely, injection devices for administering drugs and vaccines sold empty; drug delivery injection devices for administering drugs and vaccines, namely, medical injectors, needle-free injectors and structural parts therefor sold empty; actuator devices for use in drug delivery devices, namely, handheld spring-powered devices in the nature of needle-free injection systems for injecting pharmaceutical and veterinary preparations into the skin sold empty; drug cassettes for use in drug delivery devices in the nature of drug and vaccine delivery systems sold empty to contain pharmaceutical preparations and substances for therapeutic, prophylactic and diagnostic use; replacement parts for all the aforesaid goods

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 10, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 10, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEnesi Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameEnesi Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAbingdon, Oxfordshire OX144RU
GB

Party NameEnesi Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, May 31, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, June 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 12, 2018APPLICATION FILING RECEIPT MAILED
Friday, June 29, 2018ASSIGNED TO EXAMINER
Monday, July 2, 2018NON-FINAL ACTION WRITTEN
Tuesday, July 3, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, July 12, 2018REFUSAL PROCESSED BY MPU
Thursday, July 12, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 27, 2018REFUSAL PROCESSED BY IB
Tuesday, September 25, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 25, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 25, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 3, 2018FINAL REFUSAL WRITTEN
Wednesday, October 3, 2018FINAL REFUSAL E-MAILED
Wednesday, October 3, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, October 31, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, October 31, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 1, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 14, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 8, 2019PUBLISHED FOR OPPOSITION
Tuesday, January 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, June 26, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 30, 2019FINAL DISPOSITION PROCESSED
Tuesday, July 30, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 16, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, October 3, 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, November 5, 2019TEAS SECTION 7 REQUEST RECEIVED
Monday, December 9, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 3, 2020NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
Thursday, June 4, 2020COUNTERCLAIM OPP. NO. 999999
Tuesday, March 26, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, October 10, 2025CANCELLED SECTION 71